VIVOS THERAPEUTICS, INC.

Lobbying Spend

—

Filings

Firms Hired

Active Period

2020–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	4	1
2024	—	5	1
2023	—	4	1
2022	—	4	1
2021	—	4	1
2020	—	4	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
BELL & LINDSAY, INC. (FORMERLY WHITE HOUSE CONSULTING INC.)	—	28

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	27
SENATE	27
Food & Drug Administration (FDA)	23
Executive Office of the President (EOP)	21

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	28

VIVOS THERAPEUTICS, INC. — Lobbying Disclosure | Poliscope